Per-Anders Abrahamsson (Former)
81 – 90 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
The role of PSA kinetics in the management of prostate cancer
(
- Contribution to journal › Article
-
Mark
The Prostate Cancer Prevention Trial and its implications for clinical practice: A European consensus
(
- Contribution to journal › Article
-
Mark
Advances in Biomarkers for Prostate Diseases
2006) p.85-85(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2005
-
Mark
Expression of Serotonin Receptors 2B and 4 in Human Prostate Cancer Tissue and Effects of Their Antagonists on Prostate Cancer Cell Lines.
(
- Contribution to journal › Article
-
Mark
The 5alpha-Reductase Type II A49T and V89L High-Activity Allelic Variants are More Common in Men with Prostate Cancer Compared with the General Population.
(
- Contribution to journal › Article
-
Mark
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
(
- Contribution to journal › Scientific review
-
Mark
Prognostic value of serum markers for prostate cancer
(
- Contribution to journal › Article
-
Mark
Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer.
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence.
(
- Contribution to journal › Article
-
Mark
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
(
- Contribution to journal › Article